Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study

被引：0

作者：

Bibian M. E. Tullemans

Sanne L. N. Brouns

Frauke Swieringa

Siamack Sabrkhany

Franchette W. P. J. van den Berkmortel

Natascha A. J. B. Peters

Peter de Bruijn

Stijn L. W. Koolen

Johan W. M. Heemskerk

Maureen J. B. Aarts

Marijke J. E. Kuijpers

机构：

[1] Maastricht University,Cardiovascular Research Institute Maastricht, Department of Biochemistry

[2] Synapse Research Institute,Cardiovascular Research Institute Maastricht, Department of Physiology

[3] Maastricht University,Department of Medical Oncology

[4] Zuyderland Medical Centre,Department of Internal Medicine

[5] Sint Jans Gasthuis,Department of Medical Oncology, Erasmus MC Cancer Institute

[6] Erasmus University Medical Centre,Thrombosis Expertise Centre, Heart and Vascular Centre

[7] Department of Pharmacy,undefined

[8] Erasmus University Medical Centre,undefined

[9] Department of Medical Oncology,undefined

[10] Maastricht University Medical Centre+,undefined

[11] Maastricht University Medical Centre,undefined

来源：

BMC Cancer | / 22卷

关键词：

Platelet count; Platelet aggregation; Sunitinib; Tyrosine kinase inhibitor; Renal cell carcinoma; cancer; Patients; Plasma; Serum; Bleeding;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用